Hydrazine → HCID 178486415, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[C:16]([CH3:21])[C:17]([O:19][CH3:20])=[CH:18][C:13]=2[NH:12][C:11](=S)[CH2:10][N:9]=1.CO[C:25](OC)([N:27](C)C)[CH3:26].[NH2:32]N>>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[C:16]([CH3:21])[C:17]([O:19][CH3:20])=[CH:18][C:13]=2[N:12]=[C:11]2[NH:32][NH:27][C:25]([CH3:26])=[C:10]2[N:9]=1Komponenten
4
Versuchsvorschrift
5-(2-chlorophenyl)-1,2-dihydro-3,7-dimethyl-8-methoxy-pyrazolo[3,4-b][1,4]benzodiazepine (IVz) was prepared by reacting 0.0005 moles of 5-(2-chlorophenyl)-1,3-dihydro-8-methoxy-7-methyl-2H-1,4-benzodiazepin-2-thione (IIz) with 1,1-dimethoxy-N,N-dimethyl-ethanamine and then hydrazine in a manner analogous to Example 55. MH+/Z=353.
Quellen und Nachweise
- ORD-Eintrag
- ord-4319a758754745fbbe05ae6fb7144550
- Quelldatensatz
- uspto-grants-2009_04
- Patentnummer
- US07524840B2
Notizen zur Reaktion
Wird geladen…